Vivo Bio Tech Ltd Valuation
511509 · Healthcare · Current price
Is Vivo Bio Tech Ltd undervalued?
We have not published a fair value estimate for Vivo Bio Tech Ltd yet. Our valuation engine covers the market in waves, and this company has not been through a run that met our publishing bar. Rather than show a second, inconsistent number here, we would rather show none. The ratios, peer comparison and methodology below are still based on Vivo Bio Tech Ltd's reported financials.
Valuation multiples
Vivo Bio Tech Ltd trades at a P/E of 4.4x and a P/B of 0.5x, with a dividend yield of 0.0%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
How we estimate fair value
When we publish an estimate for Vivo Bio Tech Ltd, it will appear here with the full working: the models used and their weights, every assumption and its source, the confidence band, and what data was missing. That is the same methodology we apply to every company.
Read the full fair-value methodologyUnderstand the ratios
More on Vivo Bio Tech Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.

